Antonelli, Alessandro

Hashimotos' thyroiditis: epidemiology, pathogenesis, clinic and therapy

Ragusa, F., Fallahi, P., Elia, G., Gonnella, D., Paparo, S. R., Giusti, C., Churilov, L. P., Ferrari, S. M., & Antonelli, A. (2019) · Best Practice & Research Clinical Endocrinology & Metabolism

Thyroid Disorders and TreatmentsThyroid Cancer Diagnosis and Treatment

Cited by 655

Chemokine (C–X–C motif) ligand (CXCL)10 in autoimmune diseases

Antonelli, A., Ferrari, S. M., Giuggioli, D., Ferrannini, E., Ferri, C., & Fallahi, P. (2014) · Autoimmunity Reviews

Chemokine receptors and signalinginterferon and immune responses

Cited by 595

Gastrointestinal malabsorption of thyroxine

Virili, C., Antonelli, A., Santaguida, M. G., Benvenga, S., & Centanni, M. (2019) · Endocrine Reviews

Thyroid Disorders and TreatmentsDrug Solubulity and Delivery Systems

Cited by 164

3,5‐Diiodo‐ L ‐thyronine powerfully reduces adiposity in rats by increasing the burning of fats

Lanni, A., Moreno, M., Lombardi, A., De Lange, P., Silvestri, E., Ragni, M., Farina, P., Baccari, G. C., Fallahi, P., Antonelli, A., et al. (2005) · The FASEB Journal

Adipose Tissue and MetabolismThyroid Disorders and Treatments

Cited by 134

Autoimmune endocrine dysfunctions associated with cancer immunotherapies

Ferrari, S. M., Fallahi, P., Elia, G., Ragusa, F., Ruffilli, I., Patrizio, A., Galdiero, M. R., Baldini, E., Ulisse, S., Marone, G., et al. (2019) · International Journal of Molecular Sciences

Cancer Immunotherapy and BiomarkersAdrenal Hormones and Disorders

Cited by 107

TSH normalization in bariatric surgery patients after the switch from L-Thyroxine in tablet to an oral liquid formulation

Fallahi, P., Ferrari, S. M., Camastra, S., Politti, U., Ruffilli, I., Vita, R., Navarra, G., Benvenga, S., & Antonelli, A. (2017) · Obesity Surgery

Bariatric Surgery and OutcomesThyroid Disorders and Treatments

Cited by 81

Novel pyrazolopyrimidine derivatives as tyrosine kinase inhibitors with antitumoral activity in vitro and in vivo in papillary dedifferentiated thyroid cancer

Antonelli, A., Bocci, G., La Motta, C., Ferrari, S. M., Fallahi, P., Fioravanti, A., Sartini, S., Minuto, M., Piaggi, S., Corti, A., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism

Thyroid Cancer Diagnosis and TreatmentHeterocyclic Compound Synthesis and Bioactivity

Cited by 66

Levothyroxine therapy: changes of TSH levels by switching patients from tablet to liquid formulation. a systematic review and meta-analysis

Virili, C., Giovanella, L., Fallahi, P., Antonelli, A., Santaguida, M. G., Centanni, M., & Trimboli, P. (2018) · Frontiers in Endocrinology

Thyroid Disorders and TreatmentsThyroid and Parathyroid Surgery

Cited by 61

Thyroid dysfunctions induced by tyrosine kinase inhibitors

Fallahi, P., Ferrari, S. M., Vita, R., Di Domenicantonio, A., Corrado, A., Benvenga, S., & Antonelli, A. (2014) · Expert Opinion on Drug Safety

Thyroid Disorders and TreatmentsThyroid Cancer Diagnosis and Treatment

Cited by 60

New therapies for dedifferentiated papillary thyroid cancer

Fallahi, P., Mazzi, V., Vita, R., Ferrari, S., Materazzi, G., Galleri, D., Benvenga, S., Miccoli, P., & Antonelli, A. (2015) · International Journal of Molecular Sciences

Thyroid Cancer Diagnosis and TreatmentThyroid and Parathyroid Surgery

Cited by 58

Oral L-thyroxine liquid versus tablet in patients with hypothyroidism without malabsorption: a prospective study

Fallahi, P., Ferrari, S. M., & Antonelli, A. (2016) · Endocrine

Thyroid Disorders and TreatmentsThyroid and Parathyroid Surgery

Cited by 53

Do not forget nephrotic syndrome as a cause of increased requirement of levothyroxine replacement therapy

Benvenga, S., Vita, R., Di Bari, F., Fallahi, P., & Antonelli, A. (2015) · European Thyroid Journal

Thyroid Disorders and TreatmentsAdrenal Hormones and Disorders

Cited by 37

Patients with lactose intolerance absorb liquid levothyroxine better than tablet levothyroxine

Fallahi, P., Ferrari, S. M., Marchi, S., De Bortoli, N., Ruffilli, I., & Antonelli, A. (2017) · Endocrine

Thyroid Disorders and TreatmentsDigestive system and related health

Cited by 31

Differential modulation of CXCL8 versus CXCL10, by cytokines, PPAR-gamma, or PPAR-alpha agonists, in primary cells from Graves' disease and ophthalmopathy

Ferrari, S. M., Ragusa, F., Paparo, S. R., Nasini, F., Nardi, M., Franceschini, S. S., Fallahi, P., & Antonelli, A. (2019) · Autoimmunity Reviews

Ophthalmology and Eye DisordersChemokine receptors and signaling

Cited by 26

Increased requirement of replacement doses of levothyroxine caused by liver cirrhosis.

Benvenga, S., Capodicasa, G., Perelli, S., Ferrari, S. M., Fallahi, P., & Antonelli, A. (2018) · Frontiers in Endocrinology

Thyroid Disorders and TreatmentsAdrenal Hormones and Disorders

Cited by 25

Refractory hypothyroidism due to improper storage of levothyroxine tablets

Benvenga, S., Papi, G., & Antonelli, A. (2017) · Frontiers in Endocrinology

Thyroid Disorders and TreatmentsPharmacy and Medical Practices

Cited by 22

Seeking optimization of LT4 treatment in patients with differentiated thyroid cancer

Stramazzo, I., Capriello, S., Antonelli, A., Fallahi, P., Centanni, M., & Virili, C. (2022) · HORMONES

Thyroid Cancer Diagnosis and TreatmentThyroid Disorders and Treatments

Cited by 9